Codes / ICD10CM / M1A.1790

M1A.1790 Lead-induced chronic gout, unspecified ankle and foot, without tophus (tophi)

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Lead-Induced Chronic Gout, Unspecified Ankle and Foot, Without Tophus (Tophi)

Summary

Lead-induced chronic gout is a form of arthritis caused by prolonged lead exposure, leading to elevated uric acid levels and recurrent joint inflammation. This specific presentation affects the ankle and foot, without the presence of tophi (nodular deposits), resulting in persistent symptoms and potential tissue damage if untreated.

Causes

This condition results from chronic lead exposure, which disrupts uric acid metabolism and causes crystal accumulation in joints. Lead interferes with renal excretion of uric acid, leading to hyperuricemia and subsequent joint inflammation. Exposure sources include occupational contact, contaminated environments, or historical lead-based products.

Risk Factors

  • Long-term occupational or environmental lead exposure
  • History of gout or hyperuricemia
  • Male gender
  • Middle-aged or older adults

Symptoms

  • Recurrent episodes of intense joint pain in the ankle or foot
  • Persistent swelling, redness, and warmth in the affected area
  • Stiffness and limited mobility in the ankle or foot
  • Flare-ups triggered by stress, diet, or illness

Diagnosis

Diagnosis involves clinical evaluation, laboratory tests, and imaging. Blood tests measure uric acid levels, while joint fluid analysis detects urate crystals. Imaging (e.g., X-rays or ultrasounds) assesses joint damage and confirms the absence of tophi.

Treatment Options

Treatment focuses on reducing uric acid levels and managing symptoms. Medications may include urate-lowering agents, anti-inflammatories, or colchicine. Avoiding lead exposure and dietary modifications (e.g., limiting purines) are also recommended.

Prognosis and Follow-Up

With proper management, symptoms can be controlled, but chronic exposure may lead to ongoing joint damage. Regular monitoring of uric acid levels and joint function is essential to prevent progression.

Complications

Untreated or poorly managed cases may result in joint deformity, chronic pain, or reduced mobility. Persistent hyperuricemia increases the risk of kidney stones or renal impairment.

Lifestyle & Prevention

  • Minimize lead exposure through occupational safety measures or environmental testing.
  • Maintain a balanced diet low in purines to reduce uric acid production.
  • Stay hydrated to support renal function and uric acid excretion.
  • Avoid alcohol and sugary beverages, which can trigger flare-ups.

When to Seek Professional Help

Seek care if experiencing severe joint pain, swelling, or stiffness that persists or worsens. Prompt evaluation is necessary to prevent long-term damage and address potential complications.

Tips for Medical Coders

Document the absence of tophi and specify the affected site (unspecified ankle and foot) to accurately reflect the condition. Ensure lead exposure history and clinical findings support the diagnosis for proper coding.

Book a walkthrough

M1A.1790 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.